biotech

Ignite It
2 min read • July 5, 2022

Anebulo’s ANEB-001 Reduces Cannabis Intoxication In Healthy Participants

Ignite It
3 min read • June 23, 2022

This Pharmaceutical Company Is Moving Beyond CBD

Ignite It
7 min read • June 22, 2022

EXCLUSIVE: Adjusting Cannabis Compounds, Can Genetic Modification Of Hemp Eliminate THC And Boost CBD? One Company May Have The Answer

Ignite It
2 min read • June 9, 2022

Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study

Ignite It
1 min read • May 31, 2022

MyMD Pharmaceuticals Receives Decision To Grant European Patent Titled ‘Genetically Modified Cannabis Sativa Plants And Modified Cannabinoid Compounds For Treatment Of Substance Addiction And Other Disorders’

Ignite It
3 min read • May 20, 2022

Former Detroit Lions Player Calvin Johnson Explains Why Nanotechnology Makes Medicinal Cannabis Effective For Pain

Ignite It
5 min read • May 4, 2022

FDA Issues Warning Letters To Companies Illegally Selling CBD And Delta-8 THC Products

Ignite It
2 min read • May 3, 2022

Dr. Raphael Mechoulam And Other Cannabis Scientists Attend CannMed 2022 Conference In Pasadena

Ignite It
5 min read • April 19, 2022

Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference

Ignite It
1 min read • April 19, 2022

EXCLUSIVE: Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries

Ignite It
3 min read • April 12, 2022

Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?

Ignite It
2 min read • April 6, 2022

Bioharvest Sciences Completes R&D Program, Produces Cannabis Biomass In Bioreactor

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.